PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Magnesium glycerophosphate
Presentation Product Chemical substance Chapter Items dispensed
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) caps
0905013G0AADBDB
Magnesium glycerophosphate Magnesium glycerophosphate Nutrition and Blood 3
MagnEss Gly 97.2mg (4mmol) capsules
0905013G0BHADA4
MagnEss Gly Magnesium glycerophosphate Nutrition and Blood 3
MagnEss Gly 97.2mg (4mmol) chewable tablets
0905013G0BHAADE
MagnEss Gly Magnesium glycerophosphate Nutrition and Blood 2
Mag-4 (magnesium 48.6mg (2mmol)) capsules
0905013G0BCABBM
Mag-4 Magnesium glycerophosphate Nutrition and Blood 1
MagnEss Gly 48.6mg (2mmol) capsules
0905013G0BHACBM
MagnEss Gly Magnesium glycerophosphate Nutrition and Blood 1
Mag glycerophos (mag 242.5mg/5ml (10mmol/5ml)) susp
0905013G0AACYCY
Magnesium glycerophosphate Magnesium glycerophosphate Nutrition and Blood No data available
Mag glycerophos (mag 97.2mg (4mmol)) oral pdr sach
0905013G0AABVBV
Magnesium glycerophosphate Magnesium glycerophosphate Nutrition and Blood No data available
MagnaPhate (magnesium 121.25mg/5ml (5mmol/5ml)) soln
0905013G0BBABDK
MagnaPhate Magnesium glycerophosphate Nutrition and Blood No data available
MagnaPhos 39.5mg (1.6mmol) capsules
0905013G0BGAFDB
MagnaPhos Magnesium glycerophosphate Nutrition and Blood No data available
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) tab
0905013G0AACXCX
Magnesium glycerophosphate Magnesium glycerophosphate Nutrition and Blood No data available
Magnesium glycerophosphate (magnesium 9.72mg (0.4mmol)) caps
0905013G0AADADA
Magnesium glycerophosphate Magnesium glycerophosphate Nutrition and Blood No data available
MagnEss Gly 39.5mg (1.6mmol) capsules
0905013G0BHABDB
MagnEss Gly Magnesium glycerophosphate Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.